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ABSTRACT
Travis Brown: Inactivation of Bacteriophage Φ6 on Tyvek Suit Surfaces by Chemical
Disinfection
(Under the direction of Lisa M. Casanova)
The 2014 West Africa Ebola outbreak saw a substantial number of healthcare workers
(HCWs) being infected, despite the use of personal protective equipment (PPE). PPE is intended
to protect HCWs when caring for patients with Ebola virus disease (EVD), but PPE may play a
role in the spread of Ebola in healthcare environments. Before the removal of PPE, chemical
disinfection may prevent the transfer of pathogens to HCWs, but the efficacy of common
disinfectants against enveloped viruses, such as Ebola, on PPE surfaces is relatively unknown.
The purpose of this study is to assess the efficacy of two common disinfectants, chlorine bleach
(Clorox® bleach) and quaternary ammonium (Micro-Chem Plus®), used in healthcare settings
for inactivation of enveloped viruses on PPE. The virucidal activity of the two disinfectants were
tested against bacteriophage Φ6, an enveloped, non-pathogenic surrogate for enveloped viruses,
on Tyvek suit surfaces. Virus was dried onto Tyvek suit surface, exposed to the disinfectants at
use-dilution for a contact time of one minute, and the surviving virus was quantified using a
double agar layer (DAL) assay. The Clorox® bleach and Micro-Chem Plus® produced a >3.21
log10 reduction and >4.33 log10 reduction, respectively, in Φ6 infectivity. The results of this
study suggest that chlorine bleach and quaternary ammonium are effective in the inactivation of
enveloped viruses on Tyvek suit surfaces. Chemical disinfection of PPE should be considered as
a viable method to reduce the spread of pathogenic, enveloped viruses to HCWs, patients, and
other environmental surfaces in healthcare settings.
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1. INTRODUCTION
1.1. Background
Personal protective equipment (PPE) is intended to protect health care workers (HCWs)
from pathogen exposure, but PPE can also serve as a vector for pathogen transmission to the
wearer, patient, and the surrounding environment (Casanova, Sobsey, Rutala & Sobsey, 2008).
During the 2014 West Africa Ebola outbreak, the nosocomial transmission of Ebola virus to
HCWs, despite the use of PPE, raised questions regarding the role of PPE in the transmission of
viral pathogens. Previous studies show that enveloped viruses can survive on PPE for at least 4
hours and can transfer to HCWs skin and clothing during the PPE removal process (L. Casanova,
Rutala, Weber, & Sobsey, 2010).
Infectious virus can be transferred by a contaminated surface, so the interruption of viral
transfer with chemical disinfection is vital to the control of nosocomial outbreaks (Boone &
Gerba, 2007). Disinfection of PPE could serve as an important infection control measure in
healthcare settings, but the efficacy of common disinfectants against enveloped viruses on PPE
surfaces is unknown. Disinfectant efficacy on PPE must be evaluated to assist in the selection of
an appropriate germicide. If a germicide is effective, the disinfection of PPE could become an
integral part in the PPE removal process and serve as an emergency response method for HCWs
in need of extraction.
The use of surrogate virus in disinfectant efficacy studies is recommended when
investigating a highly infectious virus like Ebola (Steinmann, 2004). Bacteriophages are often
ideal, advantageous surrogate viruses to use in virus survival and disinfectant efficacy studies (L.
M. Casanova & Waka, 2013; Hoelzer, Fanaselle, Pouillot, Van Doren, & Dennis, 2013), mainly
due to their ease of propagation and assay and lack of pathogenicity (Sinclair, Rose, Hashsham,
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Gerba, & Haas, 2012). A recent non-pathogenic, surrogate virus candidate for enveloped viruses
with human pathogenicity is bacteriophage Φ6 (Adcock et al., 2009). Bacteriophage Φ6 is a lipid
enveloped RNA virus that is a member of the Cystoviridae family and a phage of Pseudomonas
bacteria (Laurinavicius, Kakela, Bamford, & Somerharju, 2004). The lipid envelope of
bacteriophage Φ6 makes it a potential model for numerous pathogenic lipid enveloped viruses
including Ebola, influenza, and coronaviruses Severe Acute Respiratory Syndrome (SARS), and
Middle Eastern Respiratory Syndrome (MERS). There have been no studies to date that use
bacteriophage Φ6 as a surrogate virus in disinfectant efficacy experiments.
The use of bacteriophage Φ6 for studying disinfectant efficacy can increase our
understanding of enveloped virus persistence after disinfection and the degree of which PPE
contributes to nosocomial infection. Therefore, this study was done with the following aims:


Evaluate the disinfectant efficacy of sodium hypochlorite and quaternary ammonium
on Tyvek suit surfaces by the inactivation of bacteriophage Φ6.



Determine which disinfectant is most effective for inactivating enveloped viruses on
Tyvek suit surfaces
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1.2. Study Objectives
The study objectives are:


To determine the efficacy of inactivation of enveloped viruses using chemical
disinfectants.
o Quantify reduction of bacteriophage Φ6 on a Tyvek suit surface using sodium
hypochlorite and quaternary ammonium compounds



To suggest a recommendation for an effective disinfectant against enveloped viruses on
personal protective equipment surfaces.



To identify the advantages and disadvantages of using bacteriophage Φ6 as a surrogate
for enveloped viruses.
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2. LITERATURE REVIEW
2.1. Viral nosocomial infections
Nosocomial infections, or hospital-acquired infections, are infections that spread in
healthcare settings (Aitken & Jeffries, 2001). Nosocomial infections are a common cause of
morbidity in United States hospitals, with the most recent prevalence survey calculating 721,800
nosocomial infections in 2011 (Magill et al., 2014). With emerging and re-emerging viral
infections, such as severe acute respiratory syndrome coronavirus (SARS-CoV) and Ebola virus,
viral nosocomial infections are becoming of increasing concern (Edmond, Diekema, &
Perencevich, 2014; Pedrosa & Cardoso, 2011). It is difficult to quantify rates of viral nosocomial
infections due to improper surveillance techniques and differential laboratory diagnostics in
hospitals (Sattar, 2004), but it is estimated that 5-32% of all nosocomial infections can be
attributed to viruses (Valenti, Menegus, Hall, Pincus, & Douglas, 1980)
Transmission of viruses can occur through a variety of pathways, including direct and
indirect contact, airborne droplets, and vehicles, such as food, water, medical equipment, and a
variety of other environmental surfaces (Boone & Gerbia, 2007). Healthcare settings, such as
hospitals and nursing homes, in which human-to-human contact is frequent, provides optimal
conditions for an infectious outbreak (Aitken & Jeffries, 2001). Viral nosocomial infections are
of great concern for both patients and healthcare workers (HCWs) given the following two
factors: the large prevalence of pathogenic organisms and a large prevalence of
immunocompromised individuals in one contained setting (Pedrosa & Cardoso, 2011).
Fomites are porous and nonporous surfaces or objects that can harbor pathogenic
microorganisms and act as a vehicle in pathogen transmission (Boone & Gerbia, 2007).
Environmental surfaces in healthcare settings play a significant role in the transmission of
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viruses (Dancer, 2009). Despite disinfection, viruses have the ability to survive on a variety of
hospital surfaces for extended periods and times and can transfer to hands of HCWs (Otter,
Yezli, & French, 2011). Nosocomial viral transmission to an affected patient mainly occurs
through the hands of HCWs, but contaminated objects, surfaces, and air is both directly and
indirectly involved in transmission as well (Weber, Rutala, Miller, Huslage, & Sickbert-Bennett,
2010). Environmental surfaces in hospitals that can harbor viruses include patient care items,
dialysis machines, medication, bathroom surfaces, patient room surfaces, and personal protective
equipment (L. Casanova, Alfano-Sobsey, Rutala, & Sobsey, 2008; Cozad & Jones, 2003)
2.2. Survival and Transfer of Viruses on Personal Protective Equipment
Personal protective equipment (PPE) is used to prevent the transmission of pathogens to
healthcare or laboratory personnel (Edmond et al., 2014). Proper and consistent use of PPE is
essential to reducing nosocomial transmission and protecting patients and HCWs (Zellmer, Van
Hoof, & Safdar, 2015), but improper use of PPE may play a part in the transmission of viral
nosocomial infections. The West Africa Ebola outbreak saw a large number of HCWs
contracting Ebola, which was attributable to two factors: insufficient supply of PPE and variation
in the PPE donning and doffing procedures (Fischer, Hynes, & Perl, 2014). The West Africa
Ebola outbreak in 2014 and the SARS outbreak in 2002 raised concerns that HCWs could
contaminate their skin and clothes during PPE doffing, which results in self-inoculation and
spread of virus to patients, other HCWs, and fomites (L. Casanova et al., 2008)
Enveloped viruses are thought to not survive as long as naked viruses on environmental
surfaces, but enveloped viruses can survive on surfaces long enough to spread infection,
particularly in healthcare settings (Russell, Hugo, & Ayliffe, 1999). Virus survival data suggests
that enveloped viruses can remain infectious on a variety of PPE materials for at least 4 hours
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(L. Casanova et al., 2010). Considering the risk of infection involved with PPE, doffing of PPE
without contaminating skin or clothing is vital to the prevention of viral transmission to the
wearer. Contaminated PPE can spread pathogens to other surfaces in the environment that can
become a vector for pathogen transmission. Transmission of virus to HCW skin and clothing is
frequent even when following proper CDC protocol (L. Casanova et al., 2008), and the majority
of HCWs do not remove PPE in the correct order and fail to properly dispose of contaminated
PPE (Zellmer et al., 2015). In response to the Ebola outbreak of 2014, the CDC announced new
recommendations for type of PPE used when caring for patients with Ebola virus disease and
detailed guidelines for the donning and doffing processes (CDC, 2014). It is unknown if the new
guidelines are effective in preventing wearer contamination.
2.3. Interruption of Viral Transmission with Chemical Disinfection
Environmental surfaces that are contaminated can easily transfer virus, so disinfection is
vital to the interruption transmission and is an important infection control measure (Boone &
Gerbia, 2007). Disinfection is the process of eliminating pathogenic microorganisms, excluding
bacterial spores, from an inanimate surface (Rutala, 1996). Proper disinfection of a surface relies
on a variety of factors including the disinfectant-surface system, disinfectant concentration, and
contact time (Rutala, Barbee, Aguiar, Sobsey, & Weber, 2000). Improper disinfection practices
can lead to nosocomial infection outbreaks (Otter et al., 2011)
Enveloped viruses are more sensitive to chemical disinfection than naked viruses,
because of their larger size and lipophilic nature (Russell et al., 1999). Inactivation of naked
viruses by chemical disinfection is assumed to involve damage to structural and functional
proteins of the virion and its nucleic acids, but inactivation of enveloped viruses may only
depend on damage to the lipid envelope, making them more susceptible to disinfection (Klein &
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Deforest, 1983; Sattar, Springthorpe, Karim, & Loro, 1989). However, enveloped viruses may be
less susceptible to disinfectant inactivation than is realized, due to variations in natural or
stimulated environmental conditions (Sattar et al., 1989).
Interruption of virus transfer from contaminated to clean surfaces can be achieved with a
proper disinfectant (Sattar, 2004), with an ideal disinfectant having a broad spectrum of biocidal
activity. There are a variety of disinfectant classes with virucidal activity, including halogens
and cationic surfactants (Russell et al., 1999). The selection of a proper disinfectant is vital,
because use of an ineffective disinfectant product with a good surfactant can free virus from
surface without inactivating it, and thus making the virus more readily available for transfer
(Sattar, 2004). Sodium hypochlorite, a halogen class disinfectant, is a broad-spectrum
disinfectant that is commonly used is conditions where hazardous agents are present, but its
disinfectant effectiveness and cleaning ability depends upon the concentration of available
chlorine and pH of the solution (Fukuzaki, 2006). Sodium hypochlorite inactivates virions
through structural alteration, alteration of viral markers, and alteration of the viral genome
(Maillard, Hann, Baubet, & Perrin, 1998; Russell et al., 1999). Quaternary ammonium
compounds, another commonly used, broad-spectrum disinfectant, are cationic surfactants that
are most active against lipophilic, or enveloped, viruses, whose primary inactivation mechanism
is through alteration of the viral envelope (Jimenez & Chiang, 2006).
2.4. Testing for Disinfectant Efficacy
Previous studies investigating the virucidal activities of chemical germicides primarily
use two different methods: suspension testing and quantitative carrier testing. Numerous studies
have been done using suspension tests (Rutala et al., 2000), but it is suggested that disinfection
studies need to be standardized by using the carrier-based method with virus being dried onto a
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specific surface (Sattar, Springthorpe, Adegbunrin, Zafer, & Busa, 2003). The carrier-based test
method involves the inoculum in question being exposed to disinfectant after being dried onto a
model surface. Unlike the suspension test method, the carrier method closely mimics field
conditions for surface contamination and virus transmission in healthcare settings (Bellamy,
1995). Pathogens in nature are more likely to be found absorbed and/or embedded into a surface,
so the carrier-based test represents a more realistic, “worst-case-scenario” field situation, with
the virus being dried onto the surface and more difficult to decontaminate (Sattar et al., 2003).
Surrogate viruses for disinfectant efficacy experiments are recommended for when the
virus in question is highly infectious (Steinmann, 2004). Bacteriophages are often ideal,
advantageous surrogate viruses to use in virus survival and disinfectant efficacy studies (L. M.
Casanova & Waka, 2013; Hoelzer et al., 2013), mainly due to their ease of propagation and assay
and lack of pathogenicity (Sinclair et al., 2012). A recent surrogate virus candidate for enveloped
viruses with human pathogenicity is bacteriophage Φ6 (Adcock et al., 2009). Bacteriophage Φ6
is a lipid enveloped RNA virus that is a member of the Cystoviridae family and a phage of
Pseudomonas bacteria (Laurinavicius et al., 2004). The lipid envelope of bacteriophage Φ6
permits it to be modeled after numerous pathogenic lipid enveloped viruses including Ebola,
influenza, Severe Acute Respiratory Syndrome (SARS), and Middle Eastern Respiratory
Syndrome (MERS).
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3. MATERIALS AND METHODS
3.1. Preparation of Hard Water
All disinfectant dilutions were done in 400ppm hard water. The hard water was prepared
from the following two stock solutions: 14.01g NaHCO3 in 250mL Dracor water (Solution 1)
and 7.06g MgCl2 and 18.50g CaCl2 in 250mL Dracor water (Solution 2). Solution A was filtered
using a 0.22µm pore size filter, and solution B was autoclaved at 121⁰C for 20 minutes.
The hard water was prepared by adding 12mL of solution 1 to a 1000mL volumetric
flask, adding 600mL of Dracor water, adding 12mL of solution 2, and diluting to the 1000mL
mark with Dracor water. The solution was then transferred to a sterile 4L container and diluted
with 2000mL Dracor water. The final solution was then adjusted to the appropriate pH (7.6-8.0)
by adding 1N HCl dropwise.
3.2. Chemical Disinfectants
The disinfectants sodium hypochlorite (Clorox® bleach) and quaternary ammonium
(Micro-Chem®) were evaluated in terms of their effectiveness in the inactivation of
bacteriophage ϕ6 dried onto Tyvek suit surfaces. Both disinfectants required dilution and were
prepared on the same day of experimentation using hard water as the diluent. Table 3.2.1
summarizes the disinfectant type, active ingredient, and use dilution. The bleach underwent a
1:10 dilution (0.825% hypochlorite) and the Micro-Chem Plus® a 1:64 dilution. Fresh chlorine
bleach was purchased for each experiment to account for the loss of free chlorine concentration
over time.
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Table 3.2.1. Disinfectants Tested for Reduction in Infectivity
Disinfectant
Disinfectant Type
Active Ingredient
Clorox® Bleach
Halogen
8.25% sodium hypochlorite
2.25% alkyl (60% C14, 30% C16, 5%
C12, 5% C18) dimethyl benzyl
Micro-Chem
Quaternary
ammonium chlorides & 2.25% alkyl
Plus®
ammonium
(68% C12, 32% C14) dimethyl
ethylbenzyl ammonium chlorides

Use-dilution
1:10

1:64

3.3. Neutralizing Solutions
Neutralizing solutions were used to halt the disinfection process of the germicides. This
ensured a specific contact-time with the virus by chemically altering the germicide to make it
inactive. The neutralizing solutions for this study were 0.1% sodium thiosulfate for chlorine
bleach and 3% glycine for the quaternary ammonium. The selection of these neutralizing
solutions is based upon previous research (Rutala, Peacock, Gergen, Sobsey, & Weber, 2006).
Table 3.3.1 outlines the neutralizing solutions used for each germicide
Table 3.3.1. Neutralizing Solutions
Disinfectant
Neutralizing Solution
Micro-Chem®
3% glycine
Clorox® bleach
0.1% thiosulfate
3.4. Testing for Disinfectant Toxicity to Bacterial Host Cells
The disinfectant-neutralizer residues can interfere with the ability to form a lawn of
bacteria needed for the plaque assay, thus the toxic effects on bacterial host cells can influence
the quantification of surviving virus after disinfection. The Pseudomonas syringae host cells
were exposed to the sodium hypochlorite/thiosulfate and quaternary ammonium/glycine
combinations to test for any toxic effects that might interfere with the quantification of virus on
the host cell lawn.
P. syringae cell monolayers were exposed to disinfectant-neutralizer and visually
compared to controls that were not exposed to disinfectant-neutralizer on a light box. Bleach and
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quaternary ammonium solutions were diluted in 400ppm hard water to simulate the hardness of
water that may come out of the tap. For each disinfectant, 50µL of disinfectant, 950µL of the
corresponding neutralizer, and 1mL of host were prepared in 3 glass test tubes. Each
disinfectant-neutralizer-host test tube was added to a tube of top agar and then poured onto a
TSA plate. For the control trial, only host and top agar were poured onto TSA plates. The
disinfectant-neutralizer plates were visually inspected for toxic effects and compared to the
control plates after 24 hours of incubation.
3.5. Testing for Disinfectant Interference with Viral Infection
Exposure of P. syringae host cells to disinfectant-neutralizer residues can interfere with
the ability of the bacteriophage to infect the cells. If there is disinfectant interference present, the
reduction in number of plaques can be attributed to the disinfectant, when it is actually damage
to the host cells. To test for disinfectant interference, two parallel titers were done. The first titer
mixed P. syringae host cells with the disinfectant/neutralizer combination, and the second titer,
or the control, was a titer assay of the bacteriophage stock. The two titers were compared to
examine differences among the two. If the disinfectant/ neutralizer titer is significantly lower
than the control titer, this indicates that the disinfectant/neutralizer is interfered with the ability
of the bacteriophage to infect the host cells.
Disinfectants were diluted in 400 ppm to appropriate concentration. Two sets of virus
dilutions were made for the disinfectant/neutralizer titer and the control titer. A total of 10 host
tubes for each disinfectant tested were prepared with 50µL of disinfectant, 950µL of the
corresponding neutralizer, and 1mL of P. syringae host. A double agar layer (DAL) assay was
performed using the host tubes, and the control titer was done by a standard DAL.
3.6. Recovery of Bacteriophage Φ6 from Tyvek Suit Surface
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The efficiency of recovering bacteriophage Φ6 from a Tyvek suit surface was determined
using 1.5% beef extract as the eluent. Two time trials were done at 0 and 60 minutes. The Φ6
stock solution (~108 PFU/mL) was thawed and 100µL was pipetted into 900µL of PBS solution.
Six Tyvek suit carriers were autoclaved and 10µL of Φ6 in PBS solution was placed on each
carrier. For the time 0 trial, three of the carriers were immediately placed in 50mL centrifuge
tubes with 5mL of 1.5% beef extract and shaken for 20 minutes. The eluent from each centrifuge
tube was assayed along with 5 dilutions. The same procedure was done for the other carriers
after 60 minutes of contact time with Φ6 solution. A titer assay of the Φ6 virus stock was also
done to calculate concentration of stock.
3.7. Disc-based Quantitative Carrier Test Method for Virus Disinfection
A total of 6 replicate experiments were done for each disinfectant. For each experiment,
three control carriers (no disinfectant applied) and three test carriers (disinfectant applied) were
assayed. The carriers were approximately 1 cm2 coupons cut from a Tyvek suit. The protocol
used for the carrier test method for virus disinfection was adapted from methods used by Sattar et
al (2003).
The carriers were placed in separate wells of a Pyrex 9-well glass plate. The Φ6 stock
was diluted in PBS to a concentration of approximately 107 PFU/mL, and 20µL was applied to
each carrier for a target concentration of 105 PFU/mL on each carrier. The virus was left on the
surface of the carrier until it completely dried (3 hours). After the virus dried, 50µL of
disinfectant was placed on the three test carriers for one minute, and then 950µL of
corresponding neutralizing solution was placed on each. For the control carriers, 50µL of TSB
was applied for one minute, and 950µL of TSB afterwards. To elute virus from surface, 150µL
of 15% beef extract solution (pH 7.5) was added to each carrier well. The carriers gently shook
12

for 20 minutes. The eluent from each carrier was assayed along with 5 dilutions and negative
controls. For the negative controls, host cells were only exposed to TSB and disinfectantneutralizer.
To quantify the reduction in Φ6 infectivity by chemical disinfection, the concentration of
virus on the test carriers after disinfection was calculated and compared to the concentration of
virus on the control carriers. Reduction was expressed as Nt/N0, where N0 is the concentration
of virus recovered from the control carriers and Nt is the concentration of virus recovered from
the disinfectant carriers after contact time t.
3.8. Statistical Analyses
The data was stored, organized and analyzed using Microsoft Excel 2013. Before
statistical analyses, plaque assay data underwent logarithmic transformation to produce a normal
distribution. All statistical analysis was performed with a level of significance at α=0.05. For the
percent recovery, disinfectant interference, and disinfectant efficacy experiments, mean values
were reported along with 95% confidence intervals. GraphPad Prism version 6 was used to
create graphs and figures.
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4. RESULTS
4.1. Test for Viral Elution off Tyvek Surface
The efficiency of eluting Φ6 off the Tyvek suit surface was evaluated by drying virus on
Tyvek carrier and exposing the carrier to the 1.5% beef extract eluting solution. For the three
replicate experiments done, three carriers were exposed to virus and immediately put in the beef
extract solution (t=0 minutes), and three carriers were exposed to virus, allowed to dry after an
hour, and then put in beef extract solution (t=60 minutes). A total of nine carriers at each time
were examined. Viral titer of the stock solution was determined as a reference of how much virus
was applied to the carrier surface. The viral elution efficiency was quantified by calculating the
percent recovery and log10 reduction in infectious titer. The results can be seen in Table 4.1.1.
The carriers that were exposed to virus and immediately placed in 1.5% beef extract
solution and had a percent recovery of 20.2% (95% CI [19.3, 21.5]), or a 0.69 log10 (95% CI
[0.66, 0.72]) reduction in infectious titer. The carriers that were exposed to virus for 60 minutes
before being placed in the 1.5% beef extract solution had a lower percent recovery of 14.9%
(95% CI [14.4, 15.3]), or a 0.83 log10 (95% CI[0.81, 0.84]).
Table 4.1.1 Percent Recovery and Log Reduction of Φ6
Percent Recovery
Log Reduction
Trial (n=9)
(95% CI)
(95% CI)
0 Minutes
20.2 (19.3, 21.5)
0.69 (0.66, 0.72)
60 Minutes
14.9 (14.4, 15.3)
0.83 (0.81, 0.84)

4.2. Test for Disinfectant Toxicity to Bacterial Host Cells
The toxic effects of the disinfectant/neutralizer combination were observed through
visual inspection of host cell monolayers using a light box. The exposure of 1:10 Clorox® bleach
and 0.1% sodium thiosulfate residues to P. syringae host cells did not interfere with the ability to
form a lawn of bacteria needed for the DAL assay. The same result was seen for the 1:64 Micro14

Chem® and 3% glycine residues. No toxic effects were observed, and the host cells were able to
form a lawn of bacteria needed for the DAL assay.
4.3. Test for Disinfectant Interference with Φ6 Infectivity
To determine if disinfectants were interfering with the ability of Φ6 to infect host cells,
titer assays of the virus stock were performed using host cells that were exposed to
disinfectant/neutralizer combinations and host cells that were unexposed (controls). The viral
titers of the Clorox® bleach and Micro-Chem® trials were then compared to the unexposed
controls. If the 95% confidence intervals of the disinfectant/neutralizer samples overlapped with
the control sample, this suggests that there is no interference with Φ6 infectivity. The results can
be seen in Table 4.3.1.
Both the Clorox® bleach and Micro-Chem® viral titers produced 95% confidence
intervals that did not overlap with the control. The Clorox® bleach produced a significantly
higher viral titer at 10.15 PFU/mL (95% CI [10.13, 10.18]) than the control at 10.04 PFU/mL
(95% CI [10.00, 10.07]), while the Micro-Chem® produced a significantly lower viral titer at
9.48 PFU/mL (95% CI [9.38, 9.56]), suggesting a loss of 0.5 log10 when using Micro-Chem®.
Table 4.3.1 Disinfectant/Neutralizer Interference with Φ6 Infectivity
Viral titer
Sample (n=3)
95% Confidence Interval
(log10PFU/mL)
Chlorine bleach
10.15
(10.13, 10.18)
Micro-Chem
9.48
(9.38, 9.56)
Control
10.04
(10.00, 10.07)
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Figure 4.3.1. Disinfectant Interference with Φ6 Infectivity
4.4 Test for Disinfectant Efficacy against Φ6 on Tyvek Suit Surface
The log10 reductions of Φ6 infectivity on Tyvek suit surfaces by Clorox® bleach and
Micro-Chem Plus® can be seen in Table 4.4.1. The log10 reductions in each disinfectant were
calculated by two independent exposure trials, with a total of 18 carriers evaluated for each
disinfectant. For both the Clorox® bleach and Micro-Chem Plus® trials, no plaques were present
after disinfectant exposure. However, the calculations were done assuming that 1 plaque was
present in the original sample, reflecting a detection limit of 1PFU/carrier. The calculated mean
log10 reductions indicate the detection limit of the technique used. The Clorox® bleach and
Micro-Chem Plus® produced a >3.21 log10 reduction and a >4.33 log10 reduction in Φ6
infectivity at one-minute contact time, respectively. The 95% confidence intervals of the two
disinfectants do not overlap, suggesting a statistical difference in the effectiveness of the
disinfectants.
16

Table 4.4.1 Mean Log10 Reduction in Φ6 Infectivity
Mean Log10
Disinfectant
95% CI
Reduction (n=18)
Clorox® bleach
3.21
(2.59, 3.82)
Micro-Chem Plus®
4.33
(4.22, 4.44)
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Figure 4.4.1. Disinfectant log10 reduction of Φ6 on Tyvek Surface
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5. DISCUSSION
PPE may serve as a vector in the transmission of pathogenic, enveloped viruses to
HCWs, patients, and other environmental surfaces in healthcare settings. The use of chemical
disinfectants on PPE surfaces may serve as an effective infection control method, but the
efficacy of chemical disinfectants against pathogenic, enveloped human viruses is unknown. The
goal of this study was to determine the effectiveness of inactivating enveloped viruses on PPE
surfaces by chemical disinfection. The inactivation of bacteriophage Φ6, a surrogate for
pathogenic, enveloped human viruses, on Tyvek suit surfaces using common disinfectants used
in healthcare environments was evaluated. The two chemical disinfectants evaluated were
sodium hypochlorite (Clorox® bleach) and quaternary ammonium (Micro-Chem Plus®).
Potential cytotoxic effects of disinfectants and their corresponding neutralizers were
tested to determine if the disinfectant/neutralizer residues damaged the cell monolayers that are
required for the quantification of virus in the DAL assay. A previous study by Sattar et al. (2003)
suggests that disinfectants be at use-dilution for the testing of cytotoxic effects to host cell
monolayers. The Clorox® bleach and the Micro-Chem Plus® were subjected to a 1:10 and 1:64
dilution, respectively, and inactivated with 0.1% sodium thiosulfate for the bleach and 3%
glycine for the quaternary ammonium. No cytotoxic effects were observed upon visual
inspection of host cell monolayers, so the disinfectants were then further examined by testing for
interference of virus infectivity.
The exposure of host cells to disinfectant residues can interfere with the ability of the
virus to infect the cells. In virus disinfection experiments, the reduction of virus can be wrongly
attributed to inactivation by the disinfectant, when the disinfectant is actually interfering with the
ability of the virus to infect the host cell. The loss of infectivity could possibly be from
interference with viral attachment to the host cells or interference with virus replication inside
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the host cell (Sattar et al. 2003). These outcomes result in overestimation of disinfectant
effectiveness and underestimation of viral titer.
The viral titer of control samples (unexposed to disinfectant) and experimental samples
(exposed to disinfectant) were calculated, and the subsequent 95% confidence intervals were
compared to determine significance. If confidence intervals overlap, this suggests that there is no
interference occurring from exposure to the disinfectant. Both the chlorine bleach and
quaternary ammonium compound produced viral titers and 95% confidence intervals that did not
overlap with the control. Using the 95% confidence intervals to compare, the chlorine bleach
viral titer was significantly higher than the control by 0.11 log10, while the quaternary
ammonium viral titer was significantly lower than the control by 0.56 log10. The quaternary
ammonium compound produced a larger difference in viral titer, implying there was slight
interference from exposure to the disinfectant. However, the interference was minimal, so the
quaternary ammonium efficacy was still evaluated despite some interference. Due to this
interference, the log10 reduction in Micro-Chem Plus® titer is overestimated by about 0.5 log10.
Before the efficacy of a disinfectant against a virus can be assessed, the efficiency of
recovering the virus from a carrier using an eluting solution needs to be determined. The
recovery of Φ6 from Tyvek suit surfaces using 1.5% beef extract as the eluent was determined.
The virus stock (~1010 PFU/mL) was diluted in PBS to 109 PFU/mL and 10μL was placed on
each carrier (~107 PFU). For the 0 minute trial, the percent recovery was 20.2% or a 0.69 log10
reduction viral titer, and the after drying, the 60 minute trial produced a 14.9% recovery or a 0.83
log10 reduction in viral titer. Even though this is a low percent recovery of Φ6 from the Tyvek
surface, the viral titer is still high enough to observe an efficient log reduction in disinfection
efficacy experiments. For the disinfectant efficacy experiments in this study, approximately 105
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PFU are placed on each carrier. The log10 reduction of Φ6 after the virus dried on the surface still
can produce an observable reduction of >4 log10 after exposed to disinfectant.
Disinfectant efficacy was evaluated against bacteriophage Φ6, a surrogate for pathogenic,
enveloped viruses. The disinfectants evaluate were chlorine bleach (Clorox®) and quaternary
ammonium (Micro-Chem Plus®). The disinfectants were considered effective if they achieved a
3 log10 reduction in Φ6 infectivity. This threshold value was based on previous studies that
evaluate disinfectant efficacy against a variety of enveloped viruses (Rutala, 2000; Sattar, 2004).
The 1:10 (0.825% hypochlorite) Clorox® bleach produced a >3.21 (95% CI [2.59, 3.82])
log10 reduction in Φ6 infectivity at a 1 minute contact time. A contact time of 1-minute was
chosen to represent a more realistic scenario in the disinfection of Tyvek suits. This finding is
consistent with Sattar et al. (1989), which reported a 99.9% reduction, or a 3 log10 reduction, in
human coronavirus 229E after one-minute contact time with 0.10% and 0.50% sodium
hypochlorite. Another study found that 1:100 hypochlorite demonstrated a <1 log10 reduction in
surrogate SARS-CoV, Mouse Hepatitis Virus and Transmissible Gastroenteritis Virus, but the
low reduction could possibly be attributed to low concentration of hypochlorite and high chlorine
demand of medium used to suspend virus (Hulkower, Casanova, Rutala, Weber, & Sobsey,
2011). A recent study evaluated hypochlorite’s efficacy against Ebola virus on PPE, which found
that dilute concentrations of hypochlorite at 0.5% and 1% produced 2.9 and 2.2 log10 reduction,
respectively, at 1 minute contact-time, and there was no recoverable virus after 5 minute contact
time. (Cook et al., 2015). The Ebola virus disinfection study did not report disinfection efficacy
results in log10 reductions, so they were calculated from the results section, but once accounted
for, the results are very similar to the present study, which indicates bacteriophage Φ6 may be an
ideal surrogate for Ebola virus in disinfection studies. . Current recommendations are to use a
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1:10 bleach solution for the disinfection of environmental surfaces in healthcare settings (Rutala
& Weber, 2008). The present study finds that 1:10 bleach at 1-minute contact time could
possibly be an effective disinfectant for the inactivation of enveloped viruses on PPE surfaces;
however, the lower limit of the 95% confidence interval was slightly less that 3log10
The Micro-Chem Plus® at 1:64 use-dilution produced a >4.33 (95% CI [4.22,
4.44]) log10 reduction in Φ6 infectivity at one-minute contact time, suggesting that quaternary
ammonium compounds are effective in the decontamination of enveloped viruses from Tyvek
suit surfaces. However, there is an overestimation of the reduction of viral titer by approximately
0.5log10 due to interference, but even accounting for the interference, the Micro-Chem®
produces a reduction >3log10. Considering the interference, it is likely there is no difference in
efficacy between the chlorine bleach and Micro-Chem Plus®. Quaternary ammonium
compounds are membrane active agents that interact with the lipid envelope of enveloped viruses
(Gerba, 2015), so this may explain the efficacy of Micro-Chem Plus against Φ6.
There is little literature on the effects of quaternary ammonium compounds on enveloped
viruses, but this finding is consistent with the available literature. Also, it is important to note
that a wide variety of quaternary ammonium compounds are available with different active
compounds, so it is difficult to compare disinfectant efficacy in some cases. Numerous studies
have evaluated the effects of quaternary ammonium compounds against norovirus and a variety
of surrogates. Although non-enveloped virus was used, Jimenez & Chiang (2008) found that
quaternary ammonium had a 6.4 log10 reduction against feline calicivirus, a surrogate for
norovirus, at 10 minute contact time. The present study used a 1 minute contact time to represent
a worst case scenario, where a HCW does not wait around for 10 minutes for disinfection of
Tyvek suit. Also, a 10 minute contact time may not be possible in an emergency situation. The
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present study found a >3log10 reduction in viral titer after a contact time of 1 minute, suggesting
that quaternary ammonium compounds achieve disinfection standards even when contact time is
short.
The 2014 Ebola outbreak in West Africa saw a large number of nosocomial infections
among HCWs, despite the use of PPE. Chemical disinfection of PPE before removal may serve
as an infection control practice. This study shows that common disinfectants used in healthcare
settings may be effective in the reduction of enveloped virus on PPE surfaces. The chlorine
bleach and quaternary ammonium compounds effectively produced a >3 log10 reduction in Φ6
viral titer. The bleach underwent a 1:10 dilution (0.825% hypochlorite), which is the current
recommendation for disinfection of hospital surfaces, and the quaternary ammonium compound
was at use-dilution, as recommended by the manufacturer. Disinfectant toxicity to the wearer
must first be examined to identify any negative health outcomes before disinfectants are used on
PPE.
The present study finds that the disinfectants are effective in reducing viral titer on Tyvek
surface, but future research needs to focus on this application in practice. Human studies that
evaluate the transfer of Φ6 on PPE to underlying clothes and skin of HCWs need to be evaluated
before recommendations can be made. This study also finds that bacteriophage Φ6 is a viable
surrogate virus candidate in disinfectant efficacy experiments. The findings are mostly consistent
with other disinfectant efficacy experiments using a variety of other enveloped viruses. The use
of bacteriophage Φ6 as a surrogate virus for enveloped viruses may have significant implications
for future studies, due to the virus’s ease of propagation and assay and lack of pathogenicity.
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